Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Jones

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Emerging Infectious Diseases|November 21, 2023
Fatal Human Neurologic Infection Caused by Pigeon Avian Paramyxovirus-1, AustraliaSiobhan Hurley, John Sebastian Eden, John Bingham, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.
Viruses|September 23, 2022
Emerging Genotype IV Japanese Encephalitis Virus Outbreak in New South Wales, AustraliaAnnaleise R Howard-Jones, David Pham, Neisha Jeoffreys, et al.
Journal of Medicinal Chemistry|November 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 InhibitorsMartin K Himmelbauer, Zhili Xin, J Howard Jones, et al.
Journal of Paediatrics and Child Health|October 13, 2021
COVID-19 in children: I. Epidemiology, prevention and indirect impactsAnnaleise R Howard-Jones, Asha C Bowen, Margie Danchin, et al.
Journal of Paediatrics and Child Health|October 25, 2021
COVID-19 in children. II: Pathogenesis, disease spectrum and managementAnnaleise R Howard-Jones, David P Burgner, Nigel W Crawford, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of biaryl carboxylamides as potent RORγ inverse agonistsJianhua Chao, Istvan Enyedy, Kurt Van Vloten, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.
The Journal of Antibiotics|December 2, 2006
Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium spJ Enrico H Lazaro, Josiane Nitcheu, Nassira Mahmoudi, et al.
Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Emerging Infectious Diseases|November 21, 2023
Fatal Human Neurologic Infection Caused by Pigeon Avian Paramyxovirus-1, AustraliaSiobhan Hurley, John Sebastian Eden, John Bingham, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2002
Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesisRoger A Smith, Donald L Hertzog, Martin H Osterhout, et al.
Viruses|September 23, 2022
Emerging Genotype IV Japanese Encephalitis Virus Outbreak in New South Wales, AustraliaAnnaleise R Howard-Jones, David Pham, Neisha Jeoffreys, et al.
Journal of Medicinal Chemistry|November 12, 2019
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 InhibitorsMartin K Himmelbauer, Zhili Xin, J Howard Jones, et al.
Journal of Paediatrics and Child Health|October 13, 2021
COVID-19 in children: I. Epidemiology, prevention and indirect impactsAnnaleise R Howard-Jones, Asha C Bowen, Margie Danchin, et al.
Journal of Paediatrics and Child Health|October 25, 2021
COVID-19 in children. II: Pathogenesis, disease spectrum and managementAnnaleise R Howard-Jones, David P Burgner, Nigel W Crawford, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of biaryl carboxylamides as potent RORγ inverse agonistsJianhua Chao, Istvan Enyedy, Kurt Van Vloten, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonistsGaetan H Ladouceur, James H Cook, Donald L Hertzog, et al.
The Journal of Antibiotics|December 2, 2006
Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium spJ Enrico H Lazaro, Josiane Nitcheu, Nassira Mahmoudi, et al.
Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation <i>In Vivo</i>J Howard Jones, Zhili Xin, Martin Himmelbauer, et al.
Pageof 17